CTLT

Catalent, Inc.

About CTLT

Catalent, Inc. is a provider of development and manufacturing solutions for drug, cell and gene therapies biologics, vaccines, and consumer health products. The Company’s segments include Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. Its Biologics segment provides development and manufacturing for protein, plasmid DNA mRNA, cell therapy, viral vaccines and viral-based gene therapies. Its Softgel and Oral Technologies segment provide formulation, development, and manufacturing services for soft capsules, as well as large-scale manufacturing of oral solid dose forms. Its Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. Its Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for, drugs, biologics and clinical trials.

Buy US stocks in Australia starting with CTLT. Open an account and start investing today!

Market Capitalisation

$12.06B

Price-earnings ratio

Dividend yield

Volume

High today

Low today

Open price

52-week high

52-week low

CTLT FAQs

How much is one share of Catalent, Inc.?

One share of Catalent, Inc. is valued at $66.93.

What is the ticker symbol for Catalent, Inc.?

The ticker symbol for Catalent, Inc. is CTLT.

How do I buy CTLT shares in Australia?

To buy CTLT stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in CTLT

What is the 52-week high for Catalent, Inc. stock?

The Catalent, Inc. 52-week high stock price is $0.00.

What is the 52-week low for Catalent, Inc. stock?

The Catalent, Inc. 52-week low stock price is $0.00.

What is the market capitalisation of Catalent, Inc. CTLT?

As of 22/03/2023 Catalent, Inc. has a market cap of $12B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.